You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser.
Administrator
Staff member
-
cafead   Aug 01, 2022 at 10:52: AM
Administrator
Staff member
via With Lumoxiti confirmed as commercially unviable monalizumab fails its phase 3 trial in head and neck cancer.
article source